IOVANCE BIOTHERAPEUTICS, INC. Loss Contingency, Damages Sought, Value
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Loss Contingency, Damages Sought, Value of $500.00 thousand for the 0-month period ending 2016-06-03, per its 10-K filed 2019-02-28.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyDamagesSoughtValue · last filed 2023-11-07
- 2016-06-03: Loss Contingency, Damages Sought, Value 0 month $500.00K; Loss Contingency, Damages Sought, Value $500.00K.
- 2016-04-08: Loss Contingency, Damages Sought, Value $500.00K.
- 2015-09-30: Loss Contingency, Damages Sought, Value 9 month $7.75M.
| Period end | Loss Contingency, Damages Sought, Value 0 month | Loss Contingency, Damages Sought, Value | Loss Contingency, Damages Sought, Value 9 month |
|---|---|---|---|
| 2016-06-03 | $500.00K 10-K · filed 2019-02-28 | $500.00K 10-K · filed 2022-02-24 | |
| 2016-04-08 | $500.00K 10-Q · filed 2023-11-07 | ||
| 2015-09-30 | $7.75M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |